Adaptimmune Therapeutics plc (ADAPY)
OTCMKTS · Delayed Price · Currency is USD
0.0397
+0.0117 (41.79%)
Jul 16, 2026, 3:56 PM EST
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of $10.52 million as of July 17, 2026. Its market cap has decreased by -85.46% in one year.
Market Cap
10.52M
Enterprise Value
-1.35M
Revenue
5.92M
Ranking
n/a
PE Ratio
0.42
Stock Price
$0.04
ChartMarket Cap Chart
Since May 7, 2015, Adaptimmune Therapeutics's market cap has decreased from 1.22B to 10.52M, a decrease of -99.14%. That is a compound annual growth rate of -34.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 10.52M | 52.69% |
| Dec 31, 2025 | 6.89M | -95.00% |
| Dec 31, 2024 | 137.84M | -23.47% |
| Dec 29, 2023 | 180.11M | -24.70% |
| Dec 30, 2022 | 239.19M | -59.17% |
| Dec 31, 2021 | 585.77M | -29.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LianBio | 11.96M |
| Curative Biotechnology | 11.73M |
| Brainstorm Cell Therapeutics | 11.54M |
| Zenith Capital | 8.79M |
| Synlogic | 8.32M |
| NKGen Biotech | 7.84M |
| Reviva Pharmaceuticals Holdings | 7.77M |
| Biomind Labs | 7.76M |